Gerresheimer AG GXI
XETR · Germany · Process Industries
€28.18-0.76 (-2.63%)
Market open· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Gerresheimer (ETR:GXI) reported a sequential improvement in preliminary second-quarter 2026 results, with adjusted EBITDA rising more than 50% from the first quarter as operational initiatives began to contribute across all three business segments. Second-quarter revenue totaled €578 million, up fr
Investing.com -- Gerresheimer AG (ETR:GXIG) shares rose on Wednesday after the German pharmaceutical packaging and drug-delivery group reported a sharp sequential improvement in second-quarter adjusted EBITDA and said it expects a stronger second half of 2026.
Election of four shareholder representatives to the Supervisory Board Markus Sieger is new Chairman of the Supervisory Board Course set for debt reduction and comprehensive refinancing DUSSELDORF, GERMANY - September 1, 2026 (NEWMEDIAWIRE) - At ...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.